Skip to main content
. 2022 May 30;11(11):3079. doi: 10.3390/jcm11113079

Figure 6.

Figure 6

(a) A 44-year-old patient with mild structural deformity of the anterior chest wall and state after bilateral implant-removal for infection following a nipple-sparing mastectomy and immediate subpectoral implant-based reconstruction elsewhere for multifocal invasive-ductal carcinoma (pT2 pN 1a (3/3) M0) associated with an extended in situ component of the right breast and BRCA-2 mutation. (b) Three months after completed expansion (Motiva Flora® XMF-58 440 cc) and before the first session of autologous fat grafting. (c) One year after the expander-to-implant based prepectoral breast reconstruction and two sessions of autologous fat grafting (70–90 cc per breast: reversed expansion, “hybrid breast reconstruction”; Motiva Ergonomix® ERSM 275 cc).